Moved Permanently

The document has moved here.

301 Moved Permanently
  • Contact Us
  • Events
  • Media
  • Select Page


    Download our Latest Content & Literature

    ASU Analytical Development

    ASU High Potent Compound & Microbiological Testing

    ASU Impurity Research Packaged Services

    ASU Large Molecule Services

    ASU Regulatory CMC

    ASU Stability Services

    ASU Structure Characterization Pre-formulation

    Discovery DMPK 10mg

    LC MS Methods

    Immunochemistry Methods

    WIND Brochure

    Preclinical Immunology Services

    General Toxicology

    Developmental and Reproductive Toxicology

    WuXi General Toxicology

    Preclinical Development of Biologics


    Standard for Exchange of Nonclinical Data (SEND)

    A Typical Timeline for Your Biologics Toxicology Program

    Troubleshooting during In-House Validation of 3T3 NRU Phototoxicity Assay in WuXi AppTec

    Revised CFDA Guidance on Genotoxicity Testing and Data Interpretation for Phameceuticals Intended for Human Use

    Comparison Of Organ Weight In 11 to 12 Weeks Old Sprague Dawley Rats From Different Geographical Regions

    A Novel and Rapid Method for Simultaneous Determination of Arginine, Ornithine, Citrulline and Urea in in vitro Human Hepatocyte

    A Systematic Approach for Achieving High Extraction Recovery in LC-MS/MS Large Molecule Quantitation Assays

    Comparison of Two LC-MS/MS Protein Quantitation Strategies with Trastuzumab as a Model System in Rat Pharmacokinetics Study

    Liquid Chromatography and Tandem Mass Spectrometry for Quantitation of Unstable Arginine and Ornithine in the Mouse Liver, Plasma and Tumor

    Development of Validated Dry Plasma Spot Assay Platform for Cassette LC-MS/MS Analysis and Comparison with Traditional Methods in Pharmacokinetics Study

    Comprehensive Validation of Dried Blood Spot Methods in Therapeutic Drug Monitoring by LC-MSMS

    Investigation of Pre- and Postnatal Developmental Toxicity of Caffeine in Rats

    Case Study of Stability Center for Late Clinical Phase Products

    Case Study of Stability Center for Commercial Products

    WuXi AppTec Drug Metabolism and Pharmacokinetic Services

    Large Molecule Bioanalytical Service

    Spontaneous Lesions Associated with Test Article-Unrelated Deaths in Repeated Does Rat Studies

    Comparison of Organ Weight (Absolute and Relative to Brain) in Wistar Rats at Different Ages


    Wind Roadshow

    Bill Harrison

    WuXi AppTec’s Preclinical Safety Center: Suzhou, China

    Hong Li

    CMC Consideration for IND Application and WuXi AppTec’s Solution The WIND Program

    Margaret Ma

    Bioanalytical Strategies for Biologics in Preclinical Studies

    Panel Discussion

    Challenges and Strategies to Accelerate an IND Program

    Sharon Tong

    ADME and PK Attributes for Drug Discovery and Development

    Yi Jin

    WIND: Your Choice of Pathway to a Successful IND Program

    Kay Olmstead

    CMC Route to Initial IND: from Medichem to GMP Drugs

    Society of Toxicology

    Yi Jin

    A Typical Timeline for your Biologic’s Toxicology Program

    David Serota

    Maximizing Your Experience and Relationship with Your CRO